Two new fully human monoclonal antibodies have been discovered which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment (Togaviridae). They were developed by culturing immune cells isolated from an individual who had developed resistance to Chikungunya.
This shows a practical, modern application of the monoclonal antibody technique we were discussing earlier, developed from sendai virus (paramyxo).
full article: http://www.sciencedaily.com/releases/2011/02/110216111935.htm
-Catalina Angel
No comments:
Post a Comment